Review



cathe m  (Biocare Medical)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Biocare Medical cathe m
    Cathe M, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cathe+m/pmc13115125-1-8-9?v=Biocare+Medical
    Average 86 stars, based on 1 article reviews
    cathe m - by Bioz Stars, 2026-07
    86/100 stars

    Images



    Similar Products

    cathe m  (Biocare Medical)
    86
    Biocare Medical cathe m
    Cathe M, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cathe+m/pmc13115125-1-8-9?v=Biocare+Medical
    Average 86 stars, based on 1 article reviews
    cathe m - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    cat hematoxylin biocare medical cathe-m  (Biocare Medical)
    90
    Biocare Medical cat hematoxylin biocare medical cathe-m
    Cat Hematoxylin Biocare Medical Cathe M, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cathe+m/pm40431243-209-4-6?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    cat hematoxylin biocare medical cathe-m - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    hematoxylin biocare medical cathe-m  (Biocare Medical)
    90
    Biocare Medical hematoxylin biocare medical cathe-m
    Histological and quantitative analysis comparing KRAS G12D and KRAS G12D Ezh2 ΔSET mice 51 days after initiating KRAS G12D and 35 days after treatment with saline or cerulein. ( A ) Representative H&E images of pancreatic tissue. Box plots indicate the amount of lesion area as a percentage of the entire pancreatic tissue. Significance was measured by 1-way ANOVA followed by Tukey’s post hoc tests. ( B ) Representative IHC for CK19 or amylase followed by counterstaining with <t>hematoxylin</t> in cerulein-treated mice. Box plots compare the ratio of CK19 + /amylase + tissue. Significance was measured by 2-tailed unpaired Mann-Whitney U test. ( C and D ) Representative images of alcian blue histology ( C ) or periodic acid–Schiff (PSA) ( D ) histology showing advanced lesions (arrows) in saline- or cerulein-treated KRAS G12D and KRAS G12D Ezh2 ΔSET mice. Box plots compare the stained area as a percentage of ADM/PanIN lesions. Significance was measured by 2-tailed unpaired Mann-Whitney U test. Scale bar: 100 μm. For graphs, individual mice ( n = 7 mice per group) are shown and data represent mean ± minimum to maximum. * P ≤ 0.05, ** P ≤ 0.01.
    Hematoxylin Biocare Medical Cathe M, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cathe+m/pmc11948588-272-4-5?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    hematoxylin biocare medical cathe-m - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    modified lillie-mayer hematoxylin biocare medical cathe-m  (Biocare Medical)
    90
    Biocare Medical modified lillie-mayer hematoxylin biocare medical cathe-m
    Histological and quantitative analysis comparing KRAS G12D and KRAS G12D Ezh2 ΔSET mice 51 days after initiating KRAS G12D and 35 days after treatment with saline or cerulein. ( A ) Representative H&E images of pancreatic tissue. Box plots indicate the amount of lesion area as a percentage of the entire pancreatic tissue. Significance was measured by 1-way ANOVA followed by Tukey’s post hoc tests. ( B ) Representative IHC for CK19 or amylase followed by counterstaining with <t>hematoxylin</t> in cerulein-treated mice. Box plots compare the ratio of CK19 + /amylase + tissue. Significance was measured by 2-tailed unpaired Mann-Whitney U test. ( C and D ) Representative images of alcian blue histology ( C ) or periodic acid–Schiff (PSA) ( D ) histology showing advanced lesions (arrows) in saline- or cerulein-treated KRAS G12D and KRAS G12D Ezh2 ΔSET mice. Box plots compare the stained area as a percentage of ADM/PanIN lesions. Significance was measured by 2-tailed unpaired Mann-Whitney U test. Scale bar: 100 μm. For graphs, individual mice ( n = 7 mice per group) are shown and data represent mean ± minimum to maximum. * P ≤ 0.05, ** P ≤ 0.01.
    Modified Lillie Mayer Hematoxylin Biocare Medical Cathe M, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cathe+m/pm39276533-119-8-10?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    modified lillie-mayer hematoxylin biocare medical cathe-m - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    cat haematoxylin solution cathe-m  (Biocare Medical)
    90
    Biocare Medical cat haematoxylin solution cathe-m
    Histological and quantitative analysis comparing KRAS G12D and KRAS G12D Ezh2 ΔSET mice 51 days after initiating KRAS G12D and 35 days after treatment with saline or cerulein. ( A ) Representative H&E images of pancreatic tissue. Box plots indicate the amount of lesion area as a percentage of the entire pancreatic tissue. Significance was measured by 1-way ANOVA followed by Tukey’s post hoc tests. ( B ) Representative IHC for CK19 or amylase followed by counterstaining with <t>hematoxylin</t> in cerulein-treated mice. Box plots compare the ratio of CK19 + /amylase + tissue. Significance was measured by 2-tailed unpaired Mann-Whitney U test. ( C and D ) Representative images of alcian blue histology ( C ) or periodic acid–Schiff (PSA) ( D ) histology showing advanced lesions (arrows) in saline- or cerulein-treated KRAS G12D and KRAS G12D Ezh2 ΔSET mice. Box plots compare the stained area as a percentage of ADM/PanIN lesions. Significance was measured by 2-tailed unpaired Mann-Whitney U test. Scale bar: 100 μm. For graphs, individual mice ( n = 7 mice per group) are shown and data represent mean ± minimum to maximum. * P ≤ 0.05, ** P ≤ 0.01.
    Cat Haematoxylin Solution Cathe M, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cathe+m/pmc10632559__ERJ___01606___2022__Supplement-110-4-8?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    cat haematoxylin solution cathe-m - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    cat hematoxylin cathe-m  (Biocare Medical)
    90
    Biocare Medical cat hematoxylin cathe-m
    Histological and quantitative analysis comparing KRAS G12D and KRAS G12D Ezh2 ΔSET mice 51 days after initiating KRAS G12D and 35 days after treatment with saline or cerulein. ( A ) Representative H&E images of pancreatic tissue. Box plots indicate the amount of lesion area as a percentage of the entire pancreatic tissue. Significance was measured by 1-way ANOVA followed by Tukey’s post hoc tests. ( B ) Representative IHC for CK19 or amylase followed by counterstaining with <t>hematoxylin</t> in cerulein-treated mice. Box plots compare the ratio of CK19 + /amylase + tissue. Significance was measured by 2-tailed unpaired Mann-Whitney U test. ( C and D ) Representative images of alcian blue histology ( C ) or periodic acid–Schiff (PSA) ( D ) histology showing advanced lesions (arrows) in saline- or cerulein-treated KRAS G12D and KRAS G12D Ezh2 ΔSET mice. Box plots compare the stained area as a percentage of ADM/PanIN lesions. Significance was measured by 2-tailed unpaired Mann-Whitney U test. Scale bar: 100 μm. For graphs, individual mice ( n = 7 mice per group) are shown and data represent mean ± minimum to maximum. * P ≤ 0.05, ** P ≤ 0.01.
    Cat Hematoxylin Cathe M, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cathe+m/us11617787-780-6-9?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    cat hematoxylin cathe-m - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    hematoxylin cathe-m  (Biocare Medical)
    90
    Biocare Medical hematoxylin cathe-m
    Histological and quantitative analysis comparing KRAS G12D and KRAS G12D Ezh2 ΔSET mice 51 days after initiating KRAS G12D and 35 days after treatment with saline or cerulein. ( A ) Representative H&E images of pancreatic tissue. Box plots indicate the amount of lesion area as a percentage of the entire pancreatic tissue. Significance was measured by 1-way ANOVA followed by Tukey’s post hoc tests. ( B ) Representative IHC for CK19 or amylase followed by counterstaining with <t>hematoxylin</t> in cerulein-treated mice. Box plots compare the ratio of CK19 + /amylase + tissue. Significance was measured by 2-tailed unpaired Mann-Whitney U test. ( C and D ) Representative images of alcian blue histology ( C ) or periodic acid–Schiff (PSA) ( D ) histology showing advanced lesions (arrows) in saline- or cerulein-treated KRAS G12D and KRAS G12D Ezh2 ΔSET mice. Box plots compare the stained area as a percentage of ADM/PanIN lesions. Significance was measured by 2-tailed unpaired Mann-Whitney U test. Scale bar: 100 μm. For graphs, individual mice ( n = 7 mice per group) are shown and data represent mean ± minimum to maximum. * P ≤ 0.05, ** P ≤ 0.01.
    Hematoxylin Cathe M, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cathe+m/pmc09857995-115-3-5?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    hematoxylin cathe-m - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    hematoxilin cathe-m  (Biocare Medical)
    90
    Biocare Medical hematoxilin cathe-m
    Histological and quantitative analysis comparing KRAS G12D and KRAS G12D Ezh2 ΔSET mice 51 days after initiating KRAS G12D and 35 days after treatment with saline or cerulein. ( A ) Representative H&E images of pancreatic tissue. Box plots indicate the amount of lesion area as a percentage of the entire pancreatic tissue. Significance was measured by 1-way ANOVA followed by Tukey’s post hoc tests. ( B ) Representative IHC for CK19 or amylase followed by counterstaining with <t>hematoxylin</t> in cerulein-treated mice. Box plots compare the ratio of CK19 + /amylase + tissue. Significance was measured by 2-tailed unpaired Mann-Whitney U test. ( C and D ) Representative images of alcian blue histology ( C ) or periodic acid–Schiff (PSA) ( D ) histology showing advanced lesions (arrows) in saline- or cerulein-treated KRAS G12D and KRAS G12D Ezh2 ΔSET mice. Box plots compare the stained area as a percentage of ADM/PanIN lesions. Significance was measured by 2-tailed unpaired Mann-Whitney U test. Scale bar: 100 μm. For graphs, individual mice ( n = 7 mice per group) are shown and data represent mean ± minimum to maximum. * P ≤ 0.05, ** P ≤ 0.01.
    Hematoxilin Cathe M, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cathe+m/pm27306217-49-14-16?v=Biocare+Medical
    Average 90 stars, based on 1 article reviews
    hematoxilin cathe-m - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Histological and quantitative analysis comparing KRAS G12D and KRAS G12D Ezh2 ΔSET mice 51 days after initiating KRAS G12D and 35 days after treatment with saline or cerulein. ( A ) Representative H&E images of pancreatic tissue. Box plots indicate the amount of lesion area as a percentage of the entire pancreatic tissue. Significance was measured by 1-way ANOVA followed by Tukey’s post hoc tests. ( B ) Representative IHC for CK19 or amylase followed by counterstaining with hematoxylin in cerulein-treated mice. Box plots compare the ratio of CK19 + /amylase + tissue. Significance was measured by 2-tailed unpaired Mann-Whitney U test. ( C and D ) Representative images of alcian blue histology ( C ) or periodic acid–Schiff (PSA) ( D ) histology showing advanced lesions (arrows) in saline- or cerulein-treated KRAS G12D and KRAS G12D Ezh2 ΔSET mice. Box plots compare the stained area as a percentage of ADM/PanIN lesions. Significance was measured by 2-tailed unpaired Mann-Whitney U test. Scale bar: 100 μm. For graphs, individual mice ( n = 7 mice per group) are shown and data represent mean ± minimum to maximum. * P ≤ 0.05, ** P ≤ 0.01.

    Journal: JCI Insight

    Article Title: EZH2 deletion does not affect acinar regeneration but restricts progression to pancreatic cancer in mice

    doi: 10.1172/jci.insight.173746

    Figure Lengend Snippet: Histological and quantitative analysis comparing KRAS G12D and KRAS G12D Ezh2 ΔSET mice 51 days after initiating KRAS G12D and 35 days after treatment with saline or cerulein. ( A ) Representative H&E images of pancreatic tissue. Box plots indicate the amount of lesion area as a percentage of the entire pancreatic tissue. Significance was measured by 1-way ANOVA followed by Tukey’s post hoc tests. ( B ) Representative IHC for CK19 or amylase followed by counterstaining with hematoxylin in cerulein-treated mice. Box plots compare the ratio of CK19 + /amylase + tissue. Significance was measured by 2-tailed unpaired Mann-Whitney U test. ( C and D ) Representative images of alcian blue histology ( C ) or periodic acid–Schiff (PSA) ( D ) histology showing advanced lesions (arrows) in saline- or cerulein-treated KRAS G12D and KRAS G12D Ezh2 ΔSET mice. Box plots compare the stained area as a percentage of ADM/PanIN lesions. Significance was measured by 2-tailed unpaired Mann-Whitney U test. Scale bar: 100 μm. For graphs, individual mice ( n = 7 mice per group) are shown and data represent mean ± minimum to maximum. * P ≤ 0.05, ** P ≤ 0.01.

    Article Snippet: Slides were counterstained with hematoxylin (Biocare Medical, CATHE-M) and imaged using Leica Microscope DM5500B (Leica Microsystems) and LAS V4.4 software.

    Techniques: Saline, MANN-WHITNEY, Staining